ACTR3C mutations, such as p. Gly58Arg or p.Gly58Glu, might alter protein function and affect key cellular processes such as cell signaling, motility, or adhesion, which are crucial in melanoma progression (Srinivasan et al., 2021). Here, ACTR3C is linked to melanoma.